Erythropoietin (Epo) is a glycoprotein hormone that promotes the production of red blood cells. Recombinant human Epo (rhEpo) is illicitly used to improve performance in endurance sports. Doping in sports is discouraged by the screening of athletes for rhEPO in urine. The adopted test is based on a combination of isoelectric focusing and double immunoblotting, and distinguishes between endogenous and recombinant human Epo. We show here that this widely used test can occasionally lead to the false-positive detection of rhEpo (epoetin-beta) in postexercise, protein-rich urine, probably because the adopted monoclonal anti-Epo antibodies are not monospecific.

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-01-0028DOI Listing

Publication Analysis

Top Keywords

recombinant human
12
false-positive detection
8
human epo
8
urine adopted
8
detection recombinant
4
human erythropoietin
4
erythropoietin urine
4
urine strenuous
4
strenuous physical
4
physical exercise
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!